Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.47
+0.01000.22%
Post-market: 4.30-0.1700-3.80%19:23 EDT
Volume:18.75K
Turnover:82.61K
Market Cap:16.58M
PE:-0.34
High:4.57
Open:4.41
Low:4.18
Close:4.46
Loading ...

BriaCell announces common shares, warrants offering

TIPRANKS
·
12 Dec 2024

Briacell Therapeutics Corp expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
11 Dec 2024

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
02 Dec 2024

BriaCell Highlights Promising Breast Cancer Trial Results

TIPRANKS
·
26 Nov 2024

BriaCell to highlight OS, clinical benefit data of Bria-IMT in MBC patients

TIPRANKS
·
26 Nov 2024

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire
·
26 Nov 2024

BriaCell director Marc Lustig resigns

TIPRANKS
·
25 Nov 2024

BriaCell Provides Update to its Board of Directors

GlobeNewswire
·
25 Nov 2024

BriaCell Advances Cancer Treatment with New Trial

TIPRANKS
·
21 Nov 2024

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire
·
21 Nov 2024

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire
·
08 Nov 2024

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire
·
04 Nov 2024

BriaCell Therapeutics Faces Uncertain Financial Future

TIPRANKS
·
02 Nov 2024

Briacell Therapeutics Corp reports results for the quarter ended in July 31 - Earnings Summary

Reuters
·
29 Oct 2024

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

MT Newswires
·
22 Oct 2024

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire
·
22 Oct 2024